Dr. Calvin Joseph Duffaut III, MD

Dr. Duffaut practices at Orthopaedic Hospital in Los Angeles, California.

Dr. Duffaut's NPI, 1497056154, was assigned on November 11, 2010. Dr. Duffaut graduated from Keck School of Medicine of USC in 2009. Dr. Duffaut holds California license A114487.

Dr. Duffaut's primary practice is Orthopaedic Hospital, at 403 W Adams Blvd, Los Angeles, CA 90007 in Los Angeles County. The practice phone is (213) 742-1000.

Dr. Duffaut's primary practice is Orthopaedic Hospital in Los Angeles, California. Dr. Duffaut is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Orthopaedic Surgery. Dmand AI also links Dr. Duffaut to 1 more hospital, 3 group practices and clinics, 3 medical groups, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duffaut practices, 7 sites in all. Vendor and product names are available with a free account.

Pediatrics is Dr. Duffaut's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dr. Duffaut is board certified in pediatrics by the American Board of Pediatrics. Dr. Duffaut is licensed in California.

Dmand AI lists bursitis, chronic diabetes, chronic hypertension, enthesopathy in arms, hand joint or tendon inflammation, joint pain, knee injury and lower back pain among the conditions Dr. Duffaut treats.

CMS data shows 5,245 Medicare services from Dr. Duffaut across 10 procedure codes in 2024, for 406 Medicare patients. Medicare paid $164,630 for them. Every service was in an office.

CMS counts 406 Medicare patients who saw Dr. Duffaut in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have arthritis, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Duffaut's median patient age at 51, with 53% women.

In 2024, Dr. Duffaut wrote 231 Medicare Part D claims for 58 patients. 98% of them were for generic drugs. CMS names the drug for 99 of them, across 5 drugs with 11 or more claims each, at $3,000 in total drug cost. In 2023, CMS named 99 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Duffaut for performance year 2024, reported as part of a group. Dr. Duffaut accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Duffaut as offering telehealth.

Dmand AI links 1 paper to Dr. Duffaut in 2022. Dr. Duffaut's most frequent co-author is Emily Marie Miller, MD.

CMS Open Payments shows 5 general payments to Dr. Duffaut from 4 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. DePuy Synthes Sales Inc. paid the most, $188.

Dr. Duffaut graduated from Keck School of Medicine of USC in 2009.

Dr. Duffaut is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.